| CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL | Cancer Research |  | | 2017 | 545 | 1 |
|
| Revisiting IL-6 antagonism in multiple myeloma | Critical reviews in oncology/hematology | | | 2016 | 494 | 0 |
|
| Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow | Leukemia |  | | 2015 | 649 | 466 |
|
| Autocrine amplification of immature myeloid cells by IL-6 in multiple myeloma-infiltrated bone marrow | Leukemia | | | 2015 | 606 | 702 |
|
| Selective APRIL blockade delays systemic lupus erythematosus in mouse | PloS one | | | 2012 | 621 | 314 |
|
| Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesions | Rheumatology | | | 2011 | 682 | 1 |
|
| Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow | Blood | | | 2011 | 719 | 1 |
|
| Comment on "Cutting edge: FcR-like 6 is an MHC class II receptor" | The Journal of immunology | | | 2010 | 586 | 0 |
|
| CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells | European Journal of Immunology | | | 2010 | 686 | 0 |
|
| Tumors that look for their springtime in APRIL | Critical reviews in oncology/hematology | | | 2009 | 673 | 0 |
|
| Comment on "Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironment where plasmablasts mature" | The Journal of immunology | | | 2009 | 546 | 0 |
|
| In situ detection of APRIL-rich niches for plasma-cell survival and their contribution to B-cell lymphoma development | Histology and histopathology | | | 2009 | 640 | 0 |
|
| Lymph node tumor metastases: more susceptible than primary tumors to CD8(+) T-cell immune destruction | Trends in immunology | | | 2009 | 580 | 0 |
|
| Synovial tissues concentrate secreted APRIL | Arthritis research & therapy | | | 2009 | 671 | 396 |
|
| Heparan sulfate proteoglycans, Fc receptors, and DC suppression | Blood | | | 2008 | 575 | 0 |
|
| Role of the tumour necrosis family ligand APRIL in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas | European journal of cancer | | | 2008 | 586 | 0 |
|
| Direct presentation of a melanocyte-associated antigen in peripheral lymph nodes induces cytotoxic CD8+ T cells | Cancer research | | | 2008 | 636 | 0 |
|
| APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells | Blood | | | 2008 | 676 | 0 |
|
| Reconstitution of the immune system after hematopoietic stem cell transplantation in humans | Seminars in immunopathology | | | 2008 | 582 | 1,003 |
|
| APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa | The Journal of clinical investigation | | | 2008 | 677 | 952 |
|
| Role of the tumor necrosis factor ligand APRIL in Hodgkin's lymphoma: a retrospective study including 107 cases | Experimental hematology | | | 2008 | 621 | 0 |
|
| Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness | Blood | | | 2007 | 227 | 292 |
|
| Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes | European Journal of Immunology | | | 2004 | 273 | 279 |
|
